MedPath

PHENAPHEN NO.2 CAP

PHENAPHEN NO.2 CAP

Discontinued
DIN Number

02042851

Drug Class

Human

Market Date

Apr 12, 1999

Company
HC

wyeth-ayerst canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02042851
AIG Number0301255003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N02AA79 CODEIN, COMBINATIONS WITH PSYCHOLEPTICS
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:08.08
Health Canada Classification

ACTIVE INGREDIENTS (3)

ACETYLSALICYLIC ACIDActive
Strength: 325 MG / CAP
Monograph: ACETYLSALICYLIC ACID
CODEINE PHOSPHATEActive
Strength: 16.2 MG / CAP
Monograph: CODEINE PHOSPHATE
PHENOBARBITALActive
Strength: 16.2 MG / CAP
Monograph: PHENOBARBITAL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.